Navigation Links
Study Released at AHA Shows Survival to Hospital Discharge After Cardiac Arrest Doubles With Improved CPR and Impedance Threshold Device
Date:11/6/2007

Groundbreaking study looks at hospital discharge rates in seven cities,

including Largo, Fla.

ORLANDO, Fla., Nov. 6 /PRNewswire/ -- A new seven-city study on the impact of new CPR techniques supports the widespread use of the American Heart Association's new 2005 CPR guidelines, according to the study authors in a presentation at the AHA's Scientific Sessions on November 4 in Orlando. Lead author, Tom P. Aufderheide, MD, Professor of Emergency Medicine and Director of the Resuscitation Research Center in the Department of Emergency Medicine at the Medical College of Wisconsin in Milwaukee, presented the data showing a doubling of hospital discharge rates when the AHA's new CPR guidelines were consistently and effectively applied to 893 patients.

The EMS departments submitting data in the study tracked individuals who experienced cardiac arrest outside of the hospital all the way through hospital discharge. When subjects were treated with new CPR techniques including the use of the ResQPOD, an impedance threshold device (ITD), the hospital discharge rates jumped from 7.9 percent to 15.7 percent, or double the survival rate of the control group.

Aufderheide said, "This menu of interventions for patients with cardiac arrest has resulted in one of the highest overall survival rates ever documented for this devastating medical condition. It represents a major breakthrough in the treatment of cardiac arrest, which we hope will be disseminated in other systems throughout the United States."

The seven EMS departments participating in the study used AHA-recommended new CPR including increased compressions, full chest wall recoil and use of the impedance threshold device. The ResQPOD ITD is a $99 device manufactured by Advanced Circulatory Systems (ACS). The impedance threshold device received a Class IIa rating by the AHA in its 2005 Emergency Cardiac Care Guidelines. This is the highest recommendation possible given to an intervention that improves hemodynamics and improves the rate of return of spontaneous circulation after cardiac arrest.

Dr. Keith Lurie, Chief Medical Officer at Advanced Circulatory Systems, said, "There are proven technologies and practices that we know can move the needle to save lives. This is especially true when we use these therapies together. People should not have to rely on being in the right place at the right time when they experience cardiac arrest. While there remains a lot of work to further increase survival rates, the findings from this study, that survival to hospital discharge rates are doubled with this new approach, has great value for all patients who suffer from a cardiac arrest."

More information on Advanced Circulatory Systems and the ResQPOD is available at http://www.advancedcirculatory.com.

About ResQPOD

The generally cleared indication for the ResQPOD is a temporary increase in blood circulation during emergency care, hospital, clinic and home use. Studies are ongoing in the United States to evaluate the long-term benefit of the ResQPOD for indications related to patients suffering from cardiac arrest, hypotension during dialysis and severe blood loss. The references in this communication are not intended to imply specific outcome-based claims not yet cleared by the US Food and Drug Administration. Clinical study references available upon request.

Study sites:

-- Largo, FL

-- Anoka County, MN

-- Raleigh, NC

-- Omaha, NE

-- Cypress Creek, TX

-- Madison, WI

-- Milwaukee, WI

Study data:

-- 893 individuals who experienced cardiac arrest

-- Control group: 1,424 patients

-- Average age: 64 years

-- 65 percent were male


'/>"/>
SOURCE Advanced Circulatory Systems
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... Dr. Benjamin ... in non-surgical hair loss treatment. Dr. Stong is double board certified and the ... for the treatment of hair loss. Non-surgical therapies such as stem cells can ...
(Date:5/5/2016)... San Rafael, CA (PRWEB) , ... May 05, 2016 , ... ... Coach of the Year, Derek Pittman, along with his university coaching staff. Together they ... and girls, with separate sessions run for youth players ages 5-13, and high school ...
(Date:5/5/2016)... CA (PRWEB) , ... May 05, 2016 , ... ... may not seem like an intuitive activity to alleviate the pain that’s a ... effective in improving pain and function in people with arthritis. , “Physical ...
(Date:5/5/2016)... , ... May 05, 2016 , ... The Lung Institute will celebrate its ... a seminar at most clinic locations throughout the month of May. To date, the Lung ... “The rapid growth that we’ve seen is a testament to the success of this treatment ...
(Date:5/5/2016)... N.J. (PRWEB) , ... May 05, 2016 , ... ... patients with cancer, today announced a new collaboration with Imerman Angels to ... cancer anywhere in the world. , “Imerman Angels provides an emotional lifeline to patients ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... TUCSON, Ariz. , May 3, 2016  As ... twice contracted rheumatic fever, which damaged his heart. ... But by June 2013, Shepherd,s heart was ... days from death. On June 20, 2013, the ... temporary Total Artificial Heart (TAH-t). Like a heart transplant, ...
(Date:5/3/2016)... , May 3, 2016  While you may be familiar with watching a film or ... also known as ultra-high-definition or 8MP in the Medical Industry.  Ampronix  is a renowned authorized ... innovative technology. Photo - http://photos.prnewswire.com/prnh/20160502/362730 ... ... ...
(Date:5/3/2016)... , May 3, 2016 Pharmaceutical ... $55 million to a woman who says its talc-based ... awarded Gloria Ristesund $5 million in compensatory ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ... against the company. In February, the same court awarded ...
Breaking Medicine Technology: